Frank Wan Chen, MD
Internal Medicine · Fontana
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 12 years
- Stanford University School of Medicine, 2014
Offices
2 locations · Southern California Permanente Medical Group · 11,250 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital Fontana. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chen’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital Fontana/OntarioFontana, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.377, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.103, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.234, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.378, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.345, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital Fontana/Ontario
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 3 better, 3 the same, 1 worse of 7 measures. Readmissions: 0 better, 2 the same, 1 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.377 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.103 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.234 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.378 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.345 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.2 to 2.31) · 392 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.57 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 16 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15.8 · 413 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 6,015 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,678 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.38 (0.17 to 0.59) · 1,799 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.49 (1.03 to 5.96) · 334 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.34) · 106 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.39 (0.75 to 4.03) · 310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.73 (0 to 16.98) · 104 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.78 (1.58 to 9.98) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.08 (0.56 to 3.6) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.42) · 1,439 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 42 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.4 · 429 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 915 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -24.9 · 32 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 929 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 51 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.4 · 199 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.4 · 403 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,560 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 56% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$2,337
Medicare paid this office $2,337 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 63 · Health risk score 1.76. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
The office billed $16,808, Medicare allowed $3,871 and paid $2,337; for 17 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 13 | 17 | 63 | 1.76 | $16,808 | $2,337 |
| 2023 | 17 | 23 | 64 | 1.80 | $16,517 | $2,834 |
| 2021 | 15 | 26 | 66 | 2.23 | $17,994 | $3,513 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$658 in 2024
Medicaid paid $658 for 28 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 14 | $655 |
| Injection, midazolam hydrochloride, per 1 mg | 14 | $3 |
| 2024 | 28 | 2 | 14 | $658 |
| 2021 | 12 | 1 | 12 | $1,173 |
See the largest Medicaid services in earlier years
2021
| Diagnostic upper gastrointestinal endoscopy | 12 | $1,173 |
Drugs they prescribed that Part D paid
$301,036
Pharmacies billed $301,036 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 753) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
606 generic and 147 brand-name prescriptions · $301,036 in drug cost · 29 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 16 | $49,966 | $3,123 |
| Creon | 35 | $47,078 | $1,345 |
| Linzess | 62 | $37,491 | $605 |
| Mesalamine | 36 | $13,577 | $377 |
| Gavilyte-C | 232 | $5,503 | $24 |
See all 11 drugs
| Xifaxan | 16 | $49,966 | $3,123 |
| Creon | 35 | $47,078 | $1,345 |
| Linzess | 62 | $37,491 | $605 |
| Mesalamine | 36 | $13,577 | $377 |
| Gavilyte-C | 232 | $5,503 | $24 |
| Lubiprostone | 32 | $2,351 | $73 |
| Pantoprazole | 153 | $1,451 | $9 |
| Lactulose | 20 | $828 | $41 |
| Entecavir | 13 | $452 | $35 |
| Omeprazole | 23 | $232 | $10 |
| Ondansetron Odt | 15 | $134 | $9 |
Year by year
| 2024 | 753 | 370 | 0% (0) | 20% | $301,036 |
| 2023 | 811 | 363 | 0% (0) | 19% | $347,103 |
| 2022 | 818 | 364 | 0% (0) | 24% | $326,969 |
| 2021 | 556 | 329 | 0% (0) | 35% | $114,910 |
| 2020 | 93 | 62 | 0% (0) | 33% | $6,928 |
| 2019 | 13 | None | 0% (0) | None | $1,396 |
| 2018 | 23 | None | 0% (0) | None | $214 |
| 2017 | 18 | None | None | None | $519 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Xifaxan | 30 | $95,521 | $3,184 |
| Creon | 27 | $30,199 | $1,118 |
| Lialda | 32 | $20,213 | $632 |
| Linzess | 16 | $9,256 | $579 |
| Gavilyte-C | 252 | $5,378 | $21 |
| Mesalamine | 11 | $4,413 | $401 |
| Lubiprostone | 11 | $2,076 | $189 |
| Pantoprazole | 205 | $1,783 | $9 |
| Lactulose | 27 | $1,074 | $40 |
| Omeprazole | 44 | $385 | $9 |
| Prednisone | 17 | $270 | $16 |
| Dicyclomine | 13 | $254 | $20 |
2022: 12 drugs
| Xifaxan | 27 | $89,079 | $3,299 |
| Lialda | 35 | $21,805 | $623 |
| Linzess | 23 | $13,684 | $595 |
| Creon | 12 | $10,688 | $891 |
| Gavilyte-C | 208 | $3,641 | $18 |
| Pantoprazole | 172 | $1,588 | $9 |
| Peg-3350 and Electrolytes | 53 | $1,081 | $20 |
| Lactulose | 24 | $820 | $34 |
| Dicyclomine | 24 | $534 | $22 |
| Omeprazole | 54 | $411 | $8 |
| Ondansetron Odt | 12 | $171 | $14 |
| Metronidazole | 14 | $142 | $10 |
2021: 11 drugs
| Lialda | 15 | $13,730 | $915 |
| Linzess | 16 | $8,291 | $518 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C | 47 | $3,350 | $71 |
| Gavilyte-C | 108 | $1,630 | $15 |
| Peg 3350-Electrolyte | 59 | $1,595 | $27 |
| Peg-3350 and Electrolytes | 46 | $936 | $20 |
| Pantoprazole | 71 | $763 | $11 |
| Omeprazole | 38 | $346 | $9 |
| Clarithromycin | 11 | $302 | $27 |
| Amoxicillin | 12 | $168 | $14 |
| Metronidazole | 17 | $154 | $9 |
2020: 2 drugs
| Peg-3350 and Electrolytes | 17 | $364 | $21 |
| Omeprazole | 15 | $132 | $9 |
Professional record
- NPI
- 1174940357
- Trained
- Stanford University School of Medicine, 2014 · 12 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 300 Pasteur Dr, Lane 154, Stanford, CA, 94305
- NPI first listed
- 2014-03-25
- NPI last updated
- 2021-12-06
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.